Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures.

In the cystic fibrosis (CF) lung the presence of bacteria and fungi in the airways promotes an inflammatory response causing progressive lung damage, ultimately leading to high rates of morbidity and mortality. We hypothesized that polymicrobial interactions play an important role in promoting airway pathogenesis. We therefore examined the interplay between the most commonly isolated bacterial CF pathogen, Pseudomonas aeruginosa, and the most prevalent filamentous fungi, Aspergillus fumigatus, to test this. Co-culture experiments showed that in the presence of A. fumigatus the production of P. aeruginosa elastase was enhanced. This was confirmed by the presence of zones of clearance on Elastin-Congo Red (ECR) agar, which was identified as elastase by mass spectrometry. When P. aeruginosa were grown in a co-culture model with mature A. fumigatus biofilms, 60% of isolates produced significantly more elastase in the presence of the filamentous fungi than in its absence (P < .05). The expression of lasB also increased when P. aeruginosa isolates PA01 and PA14 were grown in co-culture with A. fumigatus. Supernatants from co-culture experiments were also significantly toxic to a human lung epithelial cell line (19-38% cell cytotoxicity) in comparison to supernatants from P. aeruginosa only cultures (P < .0001). Here we report that P. aeruginosa cytotoxic elastase is enhanced in the presence of the filamentous fungi A. fumigatus, suggesting that this may have a role to play in the damaging pathology associated with the lung tissue in this disease. This indicates that patients who have a co-colonisation with these two organisms may have a poorer prognosis.

[1]  R. Kolter,et al.  A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.

[2]  Li Li,et al.  Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial , 2006, Genome Biology.

[3]  S. Hirakawa,et al.  Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells , 2014, Respiratory Research.

[4]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[5]  Freya Harrison,et al.  Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.

[6]  A. Hayward,et al.  Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis , 1990, Journal of clinical microbiology.

[7]  U. Ozbek,et al.  Expression stability of six housekeeping genes: A proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. , 2003, Journal of medical microbiology.

[8]  B. Walker,et al.  Novel Inhibitors of the Pseudomonas aeruginosa Virulence Factor LasB: a Potential Therapeutic Approach for the Attenuation of Virulence Mechanisms in Pseudomonal Infection , 2011, Antimicrobial Agents and Chemotherapy.

[9]  J. Carlin,et al.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.

[10]  Craig Williams,et al.  Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. , 2007, Journal of medical microbiology.

[11]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[12]  J. Tournier,et al.  In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase , 1985, Infection and immunity.

[13]  E. Ben-Jacob,et al.  Lethal protein produced in response to competition between sibling bacterial colonies , 2010, Proceedings of the National Academy of Sciences.

[14]  B. Iglewski,et al.  Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene , 1988, Journal of bacteriology.

[15]  D. Ohman,et al.  Pseudomonas aeruginosa Elastase Provides an Escape from Phagocytosis by Degrading the Pulmonary Surfactant Protein-A , 2011, PloS one.

[16]  M. Surette,et al.  Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication , 2003, Molecular microbiology.

[17]  M. Surette,et al.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.

[18]  T. Theander,et al.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases , 1988, Infection and immunity.

[19]  S. Encarnación,et al.  Interspecies competition triggers virulence and mutability in Candida albicans–Pseudomonas aeruginosa mixed biofilms , 2014, The ISME Journal.

[20]  Gordon Ramage,et al.  Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. , 2010, FEMS microbiology letters.

[21]  J. Bargon,et al.  Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis , 2003, Mycoses.

[22]  A. Azghani Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. , 1996, American journal of respiratory cell and molecular biology.

[23]  L. Hoffman,et al.  Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.

[24]  A. Nicholson,et al.  The pathology of cystic fibrosis , 2002 .

[25]  S. Aaron,et al.  The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. , 2010, Chest.

[26]  B. Iglewski,et al.  Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa , 1986, Journal of clinical microbiology.

[27]  M. Bonten,et al.  Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  M. Singer Pathogen-pathogen interaction , 2010, Virulence.

[29]  S. Lynch,et al.  The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications , 2011, Expert review of respiratory medicine.

[30]  Martin H. Schmidt,et al.  Epidemiology and Pathogenesis , 2022 .

[31]  S. Bell,et al.  Exacerbations in cystic fibrosis: 2 · Prevention , 2007, Thorax.

[32]  J. Alcorn,et al.  Degradation of Pulmonary Surfactant Protein D by Pseudomonas aeruginosa Elastase Abrogates Innate Immune Function* , 2004, Journal of Biological Chemistry.

[33]  S. Leroy,et al.  The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.

[34]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[35]  B. Peters,et al.  Polymicrobial Interactions: Impact on Pathogenesis and Human Disease , 2012, Clinical Microbiology Reviews.

[36]  B. Finlay,et al.  Quorum sensing in bacterial virulence. , 2010, Microbiology.

[37]  C. Goss,et al.  Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis , 2007, Thorax.

[38]  M. Surette,et al.  The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. , 2011, Canadian journal of microbiology.

[39]  G. Valenza,et al.  Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[40]  J. Bargon,et al.  Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. , 1999, Respiratory medicine.

[41]  P. A. Schad,et al.  Cloning and characterization of elastase genes from Pseudomonas aeruginosa , 1987, Journal of bacteriology.

[42]  Deborah A Hogan,et al.  Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation , 2013, Microbiome.

[43]  J. Colmer,et al.  Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa , 1996, Infection and immunity.